Abstract
About this talk
I will start my presentation by sharing with the audience the importance of particle engineering for different pharmaceutical applications such as oral and inhaled products. In the second part of my talk, I will stress the importance of dry powder inhaler (DPI) devices use and their effect on treatment compliance and disease management in patients suffering from respiratory diseases (e. g. Asthma and Chronic Obstructive Pulmonary Disease [COPD]). Finally, I will be discussing the issues associated with: i) inhalation manoeuvre parameters and drug delivery by DPIs to the lungs; ii) pharmacopoeial methodologies for testing DPIs in-vitro.
Speaker
About the speaker
